HALEOS LABS cash flow

Latest FY26

Cash from operations: ₹37.2cr+9.3% on FY25
Capital spending: ₹57.9cr+277.0% on FY25
Free cash flow: −₹20.6cr₹18.7 cr in FY25
Cash from financing: ₹21.4cr−₹19.1 cr in FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	15.5	15.0	14.9	10.8
	—	0.0	0.0	0.0	0.0
	—	0.0	0.0	0.1	−0.2
	—	0.0	0.0	0.0	0.0
	—	−0.4	0.0	5.5	0.0
	—	0.0	0.0	0.0	−0.2
	—	−0.4	0.0	0.3	0.0
	—	−12.4	13.8	5.0	−0.3
	—	7.8	22.5	−5.3	−12.7
	—	−0.0	0.0	−0.0	0.0
	—	−0.1	0.1	−0.1	−0.3
	—	−44.3	38.6	−40.4	−17.8
	—	−5.8	1.1	0.8	1.3
	—	9.1	5.6	−0.2	18.1
	—	−0.6	1.3	0.2	−0.5
	—	47.5	45.9	36.3	37.6
	—	0.0	0.0	0.4	0.9
Cash from operating activities
	21.6	25.2	26.2	9.8	16.6
	—	15.9	144	17.5	36.7
	—	41.1	170	27.3	53.3
	—	−0.1	0.0	0.0	0.0
	—	−2.4	0.0	0.0	−3.3
	—	0.3	−128	0.0	−41.8
	—	6.5	8.5	3.0	0.0
	—	37.2	34.1	24.3	14.7
Cash from investing activities
	—	57.9	15.3	20.9	48.6
	—	0.0	0.4	0.1	16.9
	—	0.1	0.0	0.0	0.2
	—	−0.2	−0.0	2.3	0.1
	—	−57.9	−15.0	−18.5	−31.3
Cash from financing activities
	—	40.2	4.1	16.6	29.8
	—	15.3	17.8	17.6	8.5
	—	0.7	0.6	0.0	0.0
	—	—	—	−1.2	0.5
	—	2.3	4.3	6.3	3.5
	—	0.5	0.5	0.5	0.5
	—	21.4	−19.1	−6.6	16.9
	—	0.7	−0.1	−0.7	0.3
	—	0.7	−0.1	−0.7	0.3
	—	—	—	0.6	1.3
Reference items
	40.9	44.7	45.0	31.1	28.8
	12.6%	13.4%	13.1%	10.2%	9.1%
	−20.6	−20.6	18.7	3.4	−33.9
	—	1.9	0.7	−3.8	—
	−₹68.27	−₹68.27	₹61.87	₹11.37	−₹111.98
	—	2.09×	1.82×	3.84×	1.29×
	—	6.5	8.5	3.0	0.0
	—	2.3	4.3	6.3	3.5

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

HALEOSLABS₹1,450.60

HALEOS LABS LIMITED

· Pharma & Health

₹ CrorePeersALBERTDAVD VALIANTLAB MEDICO MEDICAMEQ ZIMLAB AAREYDRUGS NECLIFE ANUHPHRMcap ₹439 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	10.8	14.9	15.0	15.5	—
+ Finance Costs	0.0	0.0	0.0	0.0	—
+ Interest Income	-0.2	0.1	0.0	0.0	—
+ Fair Value (Gains) / Losses	0.0	0.0	0.0	0.0	—
+ Other Non-cash Items	0.0	5.5	0.0	-0.4	—
+ Other — Cash Effects are Investing / Financing	-0.2	0.0	0.0	0.0	—
+ Other Reconciling Items	0.0	0.3	0.0	-0.4	—
Changes in Working Capital
+ Inventories	-0.3	5.0	13.8	-12.4	—
+ Trade Receivables — Current	-12.7	-5.3	22.5	7.8	—
+ Other Financial Assets — Current	0.0	-0.0	0.0	-0.0	—
+ Other Financial Assets — Non-current	-0.3	-0.1	0.1	-0.1	—
+ Other Current Assets	-17.8	-40.4	38.6	-44.3	—
+ Other Non-current Assets	1.3	0.8	1.1	-5.8	—
+ Trade Payables — Current	18.1	-0.2	5.6	9.1	—
+ Other Financial Liabilities — Current	-0.5	0.2	1.3	-0.6	—
+ Other Current Liabilities	37.6	36.3	45.9	47.5	—
+ Provisions — Current	0.9	0.4	0.0	0.0	—
Cash from Operating Activities
Profit Before Tax (per I/S)	16.6	9.8	26.2	25.2	21.6
+ Total Adjustments (incl. Working Capital)	36.7	17.5	144.1	15.9	—
Cash from Operations (pre-tax)	53.3	27.3	170.3	41.1	—
+ Interest Received — Operating	0.0	0.0	0.0	-0.1	—
+ Interest Paid — Operating	-3.3	0.0	0.0	-2.4	—
+ Other Inflows / (Outflows) — Operating	-41.8	0.0	-127.7	0.3	—
+ Income Taxes Paid	0.0	3.0	8.5	6.5	—
Cash from Operating Activities	14.7	24.3	34.1	37.2	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	48.6	20.9	15.3	57.9	—
+ Disp of Fixed Assets	16.9	0.1	0.4	0.0	—
+ Interest Received — Investing	0.2	0.0	0.0	0.1	—
+ Other Inflows / (Outflows) — Investing	0.1	2.3	-0.0	-0.2	—
Cash from Investing Activities	-31.3	-18.5	-15.0	-57.9	—
Cash from Financing Activities
+ Proceeds from Borrowings	29.8	16.6	4.1	40.2	—
+ Repayment of Borrowings	8.5	17.6	17.8	15.3	—
+ Payment of Lease Liabilities	0.0	0.0	0.6	0.7	—
+ Payment of Finance Lease Liabilities	0.5	-1.2	—	—	—
+ Interest Paid	3.5	6.3	4.3	2.3	—
+ Dividends Paid	0.5	0.5	0.5	0.5	—
Cash from Financing Activities	16.9	-6.6	-19.1	21.4	—
Net Changes in Cash (pre-FX)	0.3	-0.7	-0.1	0.7	—
Net Changes in Cash	0.3	-0.7	-0.1	0.7	—
Closing Cash	1.3	0.6	—	—	—
Reference Items
EBITDA	28.8	31.1	45.0	44.7	40.9
EBITDA Margin %	9.11	10.17	13.07	13.38	12.61
Free Cash Flow (CFO − Capex)	-33.9	3.4	18.7	-20.6	-20.6
Free Cash Flow to Equity	—	-3.8	0.7	1.9	—
Free Cash Flow per Basic Share	-111.98	11.37	61.87	-68.27	-68.27
Cash Flow to Net Income	1.29	3.84	1.82	2.09	—
Cash Paid for Taxes	0.0	3.0	8.5	6.5	—
Cash Paid for Interest	3.5	6.3	4.3	2.3	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.